Effect of Vaginal Radiofrequency Therapy on Vaginal Laxity : Pilot Trial — ROSE

Vaginal Laxity Clinical Trial

Official title:
Effect of Vaginal Radiofrequency Therapy on Vaginal Laxity : Pilot Trial

Status Completed

Clinical Trial Summary

To examine the efficacy and safety of radiofrequency therapy on vaginal laxity, The investigators enrolled 30 women with vaginal laxity. Radiofrequency therapy was consisted of 2 sessions with 3 week interval. A session included 20 minutes radiofrequency therapy on vaginal mucosa. Vaginal laxity score, female sexual function index (FSFI), female sexual distress scale (FSDS), vaginal pressure, adverse events were examined. Follow up period is 3 months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Vaginal Laxity

Clinical Trial Details

NCT number	NCT04227392
Study type	Interventional
Source	Seoul National University Hospital
Contact
Status	Completed
Phase	N/A
Start date	July 1, 2018
Completion date	May 31, 2019

View Details

See also
	Status	Clinical Trial	Phase
	Completed	`NCT05707793` - Ultrasound Imaging of Core Muscles Activity in Multiparous Women With Vaginal Laxity: A Cross-Sectional Study
	Recruiting	`NCT03280446` - Evaluation Using Intragen Fractional Radiofrequency With NeuViVa for the Treatment of Vaginal Laxity and Urogynecology Symptoms.	N/A